Evasteo Pharmaceuticals

Marketing of quality finished dosages in therapeutic segments such as OBG and Gynae, Fertility, Ortho, and Neuroscience.

About Evasteo Pharmaceuticals

Evasteo Pharmaceuticals is a Healthcare company. Marketing of quality finished dosages in therapeutic segments such as OBG and Gynae, Fertility, Ortho, and Neuroscience. The company has 7 employees. Its Indian entity Evasteo Pharmaceuticals Private Limited reported revenue of β‚Ή2.71 Cr. Evasteo Pharmaceuticals offers products and services including Finished Dosages and Therapeutic Products. Its focus areas include Pharmaceuticals, Fertility, Reproductive Health and Therapeutic Segments.

Company details

Evasteo Pharmaceuticals is identified as a speciality pharmaceutical company that markets quality finished dosages across different therapeutic segments. Commitments are made to provide economical healthcare solutions, ensuring access is not denied to less privileged individuals. The company is noted for its efforts in social contributions, including environmental protection and initiatives in health and education. A team of highly talented individuals with proven track records is utilized in its operations. Focus is placed on being a model corporate citizen through these endeavors.

  • Employees 7
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website evasteo.in
  • Legal Name Evasteo Pharmaceuticals Pvt. Ltd.
  • Date of Incorporation 03 Oct, 2017
  • Jurisdiction Perinthalmanna, Kerala, India
Key Metrics
  • Indian entity revenue
    ₹2.71 Cr

    FY 2025 · -12% YoY

  • Indian entity net profit
    ₹15 Lakh

    FY 2025 · 6% margin

  • Indian entity EBITDA
    ₹36.8 Lakh

    FY 2025 · 14% margin

  • Employee Count
    7

Products & Services of Evasteo Pharmaceuticals

Evasteo Pharmaceuticals offers a comprehensive portfolio of products and services, including Finished Dosages and Therapeutic Products.

Finished Dosages
Pharmaceutical Products

Quality finished dosages are marketed for various therapeutic segments.

Therapeutic Products
Healthcare Products

Products for segments like Fertility and Ortho are provided as part of pharmaceutical offerings.

Board of directors of Evasteo Pharmaceuticals Private Limited (Evasteo Pharmaceuticals)

Evasteo Pharmaceuticals Private Limited is the primary company behind Evasteo Pharmaceuticals. The board of Evasteo Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Sreejesh, appointed in 2017. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sreejesh
DIN 07946926
Director03 Oct 20179 yrs 1 moEvasteo Pharmaceuticals Private Limited
Byju Kunnamkumaath Mangampully
DIN 07895483
Managing Director03 Oct 20179 yrs 1 moEvasteo Pharmaceuticals Private Limited
Koottilingal Sajeev
DIN 07895484
Managing Director03 Oct 20179 yrs 1 moEvasteo Pharmaceuticals Private Limited
Ajithkumar Thottathil
DIN 07895485
Director03 Oct 20179 yrs 1 moEvasteo Pharmaceuticals Private Limited

Financials of Evasteo Pharmaceuticals

Figures of Evasteo Pharmaceuticals Private Limited, the primary company behind Evasteo Pharmaceuticals, for FY 2025. Revenue was ₹2.71 Cr (-12% year on year). Net profit was ₹15 Lakh (6% margin). EBITDA was ₹36.8 Lakh (14% margin). Revenue has grown at a compounded annual rate of +3% over five years.

  • ₹2.71 CrRevenue · FY 2025 · -12% YoY
  • ₹15 LakhNet profit · 6% margin
  • ₹36.8 LakhEBITDA · 14% margin
  • ₹64 LakhPaid-up capital
  • 7Employees (provident fund records)
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Evasteo Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Evasteo Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Evasteo Pharmaceuticals

Evasteo Pharmaceuticals has 7 employees.

The primary company behind Evasteo Pharmaceuticals, Evasteo Pharmaceuticals Private Limited, reported revenue of β‚Ή2.71 Cr for FY 2025, down 12% year on year.

Evasteo Pharmaceuticals is identified as a speciality pharmaceutical company that markets quality finished dosages across different therapeutic segments. Commitments are made to provide economical healthcare solutions, ensuring access is not denied to less privileged individuals. The company is noted for its efforts in social contributions, including environmental protection and initiatives in health and education. A team of highly talented individuals with proven track records is utilized in its operations. Focus is placed on being a model corporate citizen through these endeavors.

Evasteo Pharmaceuticals offers Finished Dosages and Therapeutic Products.

Evasteo Pharmaceuticals operates through Evasteo Pharmaceuticals Private Limited.

The legal entities of Evasteo Pharmaceuticals currently have 4 directors, including Sreejesh, Byju Kunnamkumaath Mangampully, Koottilingal Sajeev and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available